🇺🇸 FDA
Patent

US 6541469

CRF receptor antagonists and methods relating thereto

expired A61PA61P1/04A61P25/00

Quick answer

US patent 6541469 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/04, A61P25/00, A61P25/08, A61P25/20